BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 32522084)

  • 41. Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.
    Shin JK; Kim HC; Yun SH; Park YA; Cho YB; Huh JW; Lee WY
    Surg Endosc; 2021 Dec; 35(12):6998-7004. PubMed ID: 33523275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transanal total mesorectal excision for abdominoperineal resection is associated with poor oncological outcomes in rectal cancer patients: A word of caution from a multicentric Canadian cohort study.
    Caycedo-Marulanda A; Verschoor CP; Brown CP; Karimuddin A; Raval M; Phang T; Vikis E; Melich G; Patel SV;
    Colorectal Dis; 2022 Apr; 24(4):380-387. PubMed ID: 34957663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncological monitoring after transanal total mesorectal excision (TaTME) for rectal neoplasia.
    Sanchon L; Bardaji M; Labro M; Curto J; Soto C; Puig A; Pastor JC; Gómez C; Osorio A; Guariglia C; Pardo S; Vidal C; Collera P
    Tech Coloproctol; 2023 Sep; 27(9):739-746. PubMed ID: 36648600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A two-centre experience of transanal total mesorectal excision.
    Buchs NC; Wynn G; Austin R; Penna M; Findlay JM; Bloemendaal AL; Mortensen NJ; Cunningham C; Jones OM; Guy RJ; Hompes R
    Colorectal Dis; 2016 Dec; 18(12):1154-1161. PubMed ID: 27218423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IRIS U kit usefulness in transanal total mesorectal excision for lower rectal cancer to avoid urethral injury.
    Ishii M; Nitta T; Kataoka J; Ueda Y; Matsutani A; Taki M; Kubo R; Ota M; Ishibashi T
    BMC Gastroenterol; 2024 Jun; 24(1):203. PubMed ID: 38886646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer.
    Zeng Z; Liu Z; Luo S; Liang Z; Huang L; Ruan L; Chen J; Jie H; Liang W; Liu H; Kang L
    Surg Endosc; 2022 Jun; 36(6):3902-3910. PubMed ID: 34448933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.
    Kagami S; Funahashi K; Koda T; Ushigome T; Kaneko T; Suzuki T; Miura Y; Nagashima Y; Yoshida K; Kurihara A
    World J Surg Oncol; 2022 Nov; 20(1):363. PubMed ID: 36376924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transanal Total Mesorectal Excision Considering the Embryology Along the Fascia in Rectal Cancer Patients.
    Yoshimitsu K; Mori S; Tanabe K; Wada M; Hamada Y; Yasudome R; Kurahara H; Arigami T; Sasaki K; Koriyama C; Higashi M; Nakajo A; Ohtsuka T
    Anticancer Res; 2023 Aug; 43(8):3597-3605. PubMed ID: 37500175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma?
    Butterworth JW; Butterworth WA; Meyer J; Giacobino C; Buchs N; Ris F; Scarpinata R
    Tech Coloproctol; 2021 Nov; 25(11):1183-1198. PubMed ID: 34562160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transanal total mesorectal excision versus laparoscopic intersphincteric resection for low rectal cancer: a propensity score matching analysis.
    Li Z; Wang Q; Ning W; Yang Q; Huang Y; Yan S; Yang B; Xie M
    Surg Endosc; 2023 Sep; 37(9):6852-6860. PubMed ID: 37308763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A quest for sphincter-saving surgery in ultralow rectal tumours-a single-centre cohort study.
    Rubinkiewicz M; Zarzycki P; Czerwińska A; Wysocki M; Gajewska N; Torbicz G; Budzyński A; Pędziwiatr M
    World J Surg Oncol; 2018 Nov; 16(1):218. PubMed ID: 30404633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transanal total mesorectal excision achieves equivalent oncologic resection compared to laparoscopic approach, but with functional consequences.
    Ong GK; Tsai B; Patron RL; Johansen O; Lane F; Melbert RB; Reidy T; Maun D
    Am J Surg; 2021 Mar; 221(3):566-569. PubMed ID: 33208226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.
    Hajibandeh S; Hajibandeh S; Eltair M; George AT; Thumbe V; Torrance AW; Budhoo M; Joy H; Peravali R
    Int J Colorectal Dis; 2020 Apr; 35(4):575-593. PubMed ID: 32124047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transanal rectal resection: an initial experience of 20 cases.
    Buchs NC; Nicholson GA; Yeung T; Mortensen NJ; Cunningham C; Jones OM; Guy R; Hompes R
    Colorectal Dis; 2016 Jan; 18(1):45-50. PubMed ID: 26639062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer.
    Neary E; Ibrahim T; Verschoor CP; Zhang L; Patel SV; Chadi SA; Caycedo-Marulanda A
    Colorectal Dis; 2024 May; 26(5):837-850. PubMed ID: 38590019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Serra-Aracil X; Zarate A; Bargalló J; Gonzalez A; Serracant A; Roura J; Delgado S; Mora-López L;
    Br J Surg; 2023 Jan; 110(2):150-158. PubMed ID: 36224406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating a tumour appropriate transanal or robotic assisted approach to total mesorectal excision in high-volume rectal cancer practice is safe and cost-effective.
    Fleming C; Fernandez B; Boissieras L; Cauvin T; Denost Q
    J Robot Surg; 2023 Oct; 17(5):1979-1987. PubMed ID: 37099264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.